Poland – Clinical Research Hub Driving Outsourcing in the Pharmaceutical Industry
The growing demands of the pharmaceutical industry and the shortage of experienced specialists are making workforce outsourcing a key strategy. Poland serves as an operational hub for regional and global projects, enabling rapid reinforcement of expertise in clinical research, medical, regulatory and compliance departments, marketing, and business analysis.

The pharmaceutical industry has been operating in a highly dynamic environment for several years. The clinical research pipeline is growing, new therapeutic areas are emerging, and at the same time, companies must operate faster and more flexibly than they did just a few years ago. Added to this are increasingly complex regulatory requirements and growing pressure for cost efficiency.
From a labor market perspective, this means that the demand for experienced specialists is growing faster than their availability.
As a headhunter working with companies in the pharmaceutical and medical sectors, I observe that more and more companies are starting to view outsourcing not just as a temporary solution, but as a component of a broader resource management strategy. From my perspective working with the industry, the biggest challenge today is not recruitment itself, but the availability of experienced specialists.
Why are pharmaceutical companies increasingly treating outsourcing as a key element of their operational strategy?
In practice, the decision to use outsourcing services very rarely stems solely from cost considerations. Much more often, it is about access to competencies and the ability to respond quickly to changing business needs.
Companies choose this model of cooperation, among other reasons, when they need to quickly fill key skills in a project, start a new clinical trial and need to increase operational resources, or want to test a new organizational structure without building permanent teams. In such situations, outsourcing allows companies to operate faster and more flexibly than in the traditional employment model.
Poland – a Clinical Research Hub in Central and Eastern Europe
For many years, Poland has been one of the key clinical research markets in the Central and Eastern European region. Every year, several hundred new clinical trials are initiated here, and global pharmaceutical companies as well as CRO organizations are increasingly developing operational teams in Poland to support international projects.
In many companies, Poland now serves as an operational hub for projects carried out across the European region, and often even globally.
Among the most sought-after profiles today are:
Clinical Trial Monitoring
• Clinical Research Associate (CRA)
• Senior CRA
• Lead CRA / Lead Monitor
• Clinical Trial Manager (CTM)
Clinical Data Management
• Medical Data Specialist
• Clinical Data Manager
Medical and Regulatory Departments
• Medical Advisor / Medical Manager
• Regulatory Affairs Specialist / Manager
• Pharmacovigilance Specialist
Marketing and Business Analysis
• Brand Manager / Product Manager
• Trade Marketing Manager
• Business Analyst
Additionally, the global increase in clinical trials, especially in areas such as oncology or rare diseases, translates into growing demand for operational teams responsible for trial monitoring and data management.
Outsourcing as Strategic Support
More and more pharmaceutical companies are treating outsourcing not as a temporary fix, but as part of a long-term organizational model.
At Antal, outsourcing today is not only support for clinical trials but also a way to quickly strengthen medical, regulatory, marketing, and analytical departments - while providing full administrative and operational support.
For HR departments, this means greater flexibility in talent management, better cost predictability, and the ability to focus on the strategic aspects of organizational development.
Learn more about Antal’s services in the pharmaceutical and clinical research sector: https://en.antal.pl/employers/services/recruitment/pharma-medical-devices
Published: April 7, 2026 by Marta Lebuda






















